Crossref
LXR Inhibits Proliferation of Human Breast Cancer Cells through the PI3K-Akt Pathway
Nuclear Receptor Research · 2015
DOI: 10.11131/2015/101154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Receptor Research, 2015. Verfasst von Treska S. Hassan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hassan, T. S., Paniccia, A., Russo, V., & Steffensen, K. R. (2015). LXR Inhibits Proliferation of Human Breast Cancer Cells through the PI3K-Akt Pathway. Nuclear Receptor Research. https://doi.org/10.11131/2015/101154
Vancouver
Hassan TS, Paniccia A, Russo V, Steffensen KR. LXR Inhibits Proliferation of Human Breast Cancer Cells through the PI3K-Akt Pathway. Nuclear Receptor Research. 2015. doi:10.11131/2015/101154
BibTeX
@article{Hassan2015,
author = {Hassan, Treska S. and Paniccia, Aida and Russo, Vincenzo and Steffensen, Knut R.},
title = {LXR Inhibits Proliferation of Human Breast Cancer Cells through the PI3K-Akt Pathway},
journal = {Nuclear Receptor Research},
year = {2015},
doi = {10.11131/2015/101154}
}
EUVIMED